Abstract
Results of the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) show significantly lower rates of coronary and stroke events in individuals allocated an amlodipine-based combination drug regimen than in those allocated an atenolol-based combination drug regimen (HR 0.86 and 0.77, respectively). Our aim was to assess to what extent these differences were due to significant differences in blood pressures and in other variables noted after randomisation.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Lancet |
Vol/bind | 366 |
Udgave nummer | 9489 |
Sider (fra-til) | 907-13 |
Antal sider | 7 |
ISSN | 0140-6736 |
DOI | |
Status | Udgivet - sep. 2005 |